These exosomes carry specific microRNAs (miRNAs), such as miR-1, miR-133a, and miR-126, which have potential as biomarkers for diagnosing DCM, as well as miRNAs like miR-30d, miR-195, miR-21 ...

However, the industry is yet to realize trehalose’s full potential. Nagase Viita ... for the saccharide through research into exosomes and other emerging modalities. Trehalose is found in ...

US biotech PureTech Health has signed a potential billion-dollar deal with Roche based around its exosome technology that allows for oral administration of complex payloads – in this case ...

The findings highlight a potential exosome-based approach for the treatment of Duchenne muscular dystrophy (DMD) by delivering phosphorodiamidate morpholino oligomers (PMOs). “We continue to ...